Vivet-Boudou V - Search Results

1

Identification of a putative Gag binding site critical for feline immunodeficiency virus genomic RNA packaging.

Krishnan A, Ali LM, Prabhu SG, Pillai VN, Chameettachal A, Vivet-Boudou V, Bernacchi S, Mustafa F, Marquet R, Rizvi TA. Krishnan A, et al. Among authors: vivet boudou v. RNA. 2023 Dec 18;30(1):68-88. doi: 10.1261/rna.079840.123. RNA. 2023. PMID: 37914398 Free PMC article.

2

Nucleoside and nucleotide inhibitors of HIV-1 replication.

Vivet-Boudou V, Didierjean J, Isel C, Marquet R. Vivet-Boudou V, et al. Cell Mol Life Sci. 2006 Jan;63(2):163-86. doi: 10.1007/s00018-005-5367-x. Cell Mol Life Sci. 2006. PMID: 16389458 Review.

3

HIV-1 reverse transcriptase inhibitors.

El Safadi Y, Vivet-Boudou V, Marquet R. El Safadi Y, et al. Appl Microbiol Biotechnol. 2007 Jun;75(4):723-37. doi: 10.1007/s00253-007-0919-7. Epub 2007 Mar 17. Appl Microbiol Biotechnol. 2007. PMID: 17370068 Review.

4

Synthesis and primary evaluation of novel HIV-1 inhibitors.

El Safadi Y, Marquet R, Aubertin AM, Vivet-Boudou V. El Safadi Y, et al. Nucleosides Nucleotides Nucleic Acids. 2007;26(8-9):1161-5. doi: 10.1080/15257770701527109. Nucleosides Nucleotides Nucleic Acids. 2007. PMID: 18058557

5

In search of new inhibitors of HIV-1 replication: synthesis and study of 1-(2'-Deoxy-beta-D-Ribofuranosyl)-1,2,4-triazole-3-carboxamide as a selective viral mutagenic agent.

Vivet-Boudou V, Paillart JC, Burger A, Marquet R. Vivet-Boudou V, et al. Nucleosides Nucleotides Nucleic Acids. 2007;26(6-7):743-6. doi: 10.1080/15257770701490902. Nucleosides Nucleotides Nucleic Acids. 2007. PMID: 18066893

6

5-Modified-2'-dU and 2'-dC as mutagenic anti HIV-1 proliferation agents: synthesis and activity.

El Safadi Y, Paillart JC, Laumond G, Aubertin AM, Burger A, Marquet R, Vivet-Boudou V. El Safadi Y, et al. J Med Chem. 2010 Feb 25;53(4):1534-45. doi: 10.1021/jm901758f. J Med Chem. 2010. PMID: 20112915

7

SHAPE analysis of the 5' end of the Mason-Pfizer monkey virus (MPMV) genomic RNA reveals structural elements required for genome dimerization.

Aktar SJ, Jabeen A, Ali LM, Vivet-Boudou V, Marquet R, Rizvi TA. Aktar SJ, et al. RNA. 2013 Dec;19(12):1648-58. doi: 10.1261/rna.040931.113. Epub 2013 Oct 23. RNA. 2013. PMID: 24152551 Free PMC article.

8

Specific recognition of the HIV-1 genomic RNA by the Gag precursor.

Abd El-Wahab EW, Smyth RP, Mailler E, Bernacchi S, Vivet-Boudou V, Hijnen M, Jossinet F, Mak J, Paillart JC, Marquet R. Abd El-Wahab EW, et al. Nat Commun. 2014 Jul 2;5:4304. doi: 10.1038/ncomms5304. Nat Commun. 2014. PMID: 24986025 Free article.

9

Structural basis of genomic RNA (gRNA) dimerization and packaging determinants of mouse mammary tumor virus (MMTV).

Aktar SJ, Vivet-Boudou V, Ali LM, Jabeen A, Kalloush RM, Richer D, Mustafa F, Marquet R, Rizvi TA. Aktar SJ, et al. Retrovirology. 2014 Nov 14;11:96. doi: 10.1186/s12977-014-0096-6. Retrovirology. 2014. PMID: 25394412 Free PMC article.

10

Evaluation of anti-HIV-1 mutagenic nucleoside analogues.

Vivet-Boudou V, Isel C, El Safadi Y, Smyth RP, Laumond G, Moog C, Paillart JC, Marquet R. Vivet-Boudou V, et al. J Biol Chem. 2015 Jan 2;290(1):371-83. doi: 10.1074/jbc.M114.616383. Epub 2014 Nov 14. J Biol Chem. 2015. PMID: 25398876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page